Abstract
Malaysia’s healthcare system consists of two sectors namely public and private sector. Ministry of Health (MOH) is the main agency providing healthcare services in public sector.
Malaysia pharmaceutical market is dominated by prescription drugs that account for approximately 60 % of the pharmaceutical market share by value. There is no price control mechanism for pharmaceuticals in Malaysia. In fact, drug prices are not regulated in Malaysia and it is left to market forces to foster competition. However, in public sector, few price control strategies are employed by MOH to ensure fair, reasonable, affordable and stable prices of drugs. Despite various strategies formulated, there are challenges that need to be addressed. In public sector, the main challenges include escalating cost of pharmaceuticals as a result of privatization of Government Medical Store, lack of implementation of pro-generics policies and overlapping role of Malaysian Health Technology Assessment (MaHTAS) and Pharmacoeconomic Unit at Pharmaceutical Service Division (PSD) in cost-effectiveness evaluation of drugs. Similarly, in private sector, majority of the private health care providers would not follow the recommended retail price in selling medicines. In conclusion, there are several challenges that need be addressed in order to have a good pharmaceutical pricing strategy in Malaysia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdul LS (1999) Regulations and policies on pharmaceuticals in Malaysia: its impact on healthcare. Kaohsiung J Med Sci 15:S75–S78
Asia Pacific Observatory on Health Systems and Policies (2013) Malaysia health system review [Online]. http://www.wpro.who.int/asia_pacific_observatory/hits/series/Malaysia_Health_Systems_Review2013.pdf. Accessed 20 Nov 2013
Azmi IM, Alavi R (2001) TRIPS, patents, technology transfer, foreign direct investment and the pharmaceutical industry in Malaysia. J World Intellect Prop 4:946–976
Babar ZUD, Izham MIM, Singh H, Bukhari NI (2005) A survey on medicine prices availability, affordability and price components in Malaysia using the WHO/HAI methodology [Online]. Malaysia. http://apps.who.int/medicinedocs/documents/s18599en/s18599en.pdf. Accessed 5 Dec 2012
Babar ZUD, Ibrahim MIM, Singh H, Bukahri NI, Creese A (2007) Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLoS Med 4:e82
Bahri S (2013) Use of health economics data in listing and pricing of pharmaceuticals: Ministry of Health perspective. Monash Health Economic Forum 2013. Monash University Malaysia, Bandar Sunway.
Bahrom S (2013) Robust growth seen for healthcare industry [Online]. https://www.freemalaysiatoday.com/category/business/2013/02/06/robust-growth-seen-for-healthcare-industry/. Accessed 11 June 2013
Bridel A (2012) Explaining 1 care: its proposals, rationale and feasibility. http://www.cpps.org.my/upload/CPPS%201Care%20Policy%20Paper.pdf. Accessed 17 Aug 2012
Business Monitor International (2013) Malaysia pharmaceuticals and healthcare report Q3 2013. Business Monitor International Ltd., London
Central Bank of Malaysia (2013) Exchange rate [Online]. http://www.bnm.gov.my/index.php?ch=statistic&pg=stats_exchangerates. Accessed 23 Oct 2013
Chua GN, Hassali MA, Shafie AA, Awaisu A (2010) A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy 95:229–235
Department of Statistic Malaysia (2013) Consumer Price Index Malaysia August 2013 [Online]. http://www.statistics.gov.my/portal/index.php?option=com_content&view=article&id=2105%3Aconsumer-price-index-malaysia-august-2013-updated-18092013&catid=71%3Aconsumer-price-index-malaysia-&Itemid=153&lang=en. Accessed 23 Oct 2013
Director General of Health Malaysia (1997) Essential Drugs Concept- An International Perspective [Online]. http://www.prn.usm.my/old_website/isdb/speech.html. Accessed 26 Nov 2013
Employees Provident Fund (2013) About EPF [Online]. http://www.kwsp.gov.my/portal/en/about-epf/overview-of-the-epf. Accessed 27 Jan 2014
Gan BZ (2013) Say no to inducement to medical prescribers [Online]. https://www.facebook.com/groups/147352308715470/permalink/428227587294606/. Accessed 25 Nov 2013
Haas JS, Phillips KA, Gerstenberger EP, Seger AC (2005) Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med 142:891–897
Hassali MA, Yuen KH, Ibrahim MIM, Wong JW, Ng BH, San Ho DS (2009) Malaysian pharmaceutical industry: opportunities and challenges. J Generic Med 6:246–252
Hassali MA, Shafie AA, Al-Haddad M, Balamurugan T, Awaisu A, Siow Y (2010) A qualitative study exploring the impact of the pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. J Clin Diagn Res 4:3161–3169
Hassali MA, Shafie AA, Babar ZUD, Khan TM (2012) A study comparing the retail drug prices between Northern Malaysia and Australia. J Pharm Health Serv Res 3:103–107
Hassali MA, Tan CS, Saleem F, Aljadhey H (2013) A qualitative exploration of perceptions toward pharmaceutical price war among community pharmacists in the state of Penang, Malaysia. J Med Mark Device Diagn Pharm Mark 13:44–53
Hassali MA, Alrasheedy AA, Ab Razak BA, Al-Tamimi SK, Saleem F, Haq NU, Aljadhey H (2014) Assessment of general public satisfaction with public healthcare services in Kedah, Malaysia. Australas Med J 7:35
Hussain SH (2008) Drug control and formulary management in Malaysia. Value Health 11:S158–S159
International Network of Agencies for Health Technology Assessment (INAHTA) (2014) MaHTAS—Health Technology Assessment Section, Ministry of Health Malaysia [Online]. http://www.inahta.org/Members/MaHTAs/. Accessed 22 April 2014
Jaafar S, Noh KM, Muttalib KA, Othman NH, Healy J, Maskon K, Abdullah AR, Zainuddin J, Bakar AA, Rahman SSA, Ismail F, Yuen CY, Baba N, Said ZM (2013) Malaysia health system review. Health Syst Transit [Online] 3(1):103. http://www.wpro.who.int/asia_pacific_observatory/hits/series/Malaysia_Health_Systems_Review2013.pdf
Kamat VR, Nichter M (1998) Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med 47:779–794
Kanavos P (2007) Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin 23:105–116
Karim SA, Pillai G, Ziqubu-Page T, Cassimjee M, Morar M (1996) Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan 11:198–202
King DR, Kanavos P (2002) Encouraging the use of generic medicines: implications for transition economies. Croat Med J 43:462–469
Kolassa E (1997) Prices politic, and problems—a pricing philosophy. J Pharm Mark Pract 1:21–27
Mahmood M, Bukhari N (2002) Pharmaceutical management and marketing. Tariq Academy, Faisalabad, pp 115–144
Malaysia Competition Commission (2010) Competition Act 2010 [Online]. http://www.mycc.gov.my/files/announcement/06c727d2-d538-43ba-99fe-40df475d0a8d.pdf. Accessed 20 Dec 2012
Malaysia External Trade Development Corporation (2013) Pharmaceutical: overview of the industry [Online]. http://www.matrade.gov.my/en/foriegn-buyers-section/69-industry-write-up--products/520-pharmaceutical. Accessed 18 Aug 2013
Malaysian Association of Pharmaceutical Suppliers (MAPS) (2014) Message from the President, June 2014 [Online]. http://www.i-maps.my/1.asp. Accessed 4 Aug 2014
Malaysian Pharmaceutical Society, Malaysian Community Pharmacy Guild (2013) Community pharmacy pricing issues and strategies required. http://www.mcpg.org.my/index.php?root=MjIy&detail=OTA=. Accessed 19 Nov 2013
Malaysian Industrial Development Authority (2011) Guide on pharmaceutical industry in Malaysia. http://www.mida.gov.my/env3/uploads/Publications_pdf/Guide_on_Pharmaceutical/Guide%20Book%20Oct%202011.pdf. Accessed 3 Feb 2013
Malaysian Medical Resource (2012) National Pharmaceutical Formulary 2012 [Online]. http://medicine.com.my/wp/2012/09/national-pharmaceutical-formulary-2012/. Accessed 26 Nov 2013
Malaysian Pharmaceutical Society (2012) An “honest-voice” against unethical promotion [Online]. MPS Announcements, Articles and News Alerts. http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3603. Accessed 15 Dec 2012
Malaysian-German Chamber of Commerce and Industry (2011) “Market Watch 2012” The healthcare sector in Malaysia. http://www.malaysia.ahk.de/fileadmin/ahk_malaysia/Market_reports/The_Healthcare_Sector_in_Malaysia.pdf. Accessed 24 April 2014
Ministry of Finance Malaysia (2013) Malaysia government procurement regime. http://www.treasury.gov.my/pdf/lain-lain/msia_regime.pdf. Accessed 23 Oct 2013
Ministry of Health Malaysia (2005) Malaysian statistics on medicine 2005 [Online]. http://www.crc.gov.my/wp-content/uploads/documents/report/msmreport_2007.pdf. Accessed 19 July 2014
Ministry of Health Malaysia (2007) Malaysian National Medicines Policy. http://www.pharmacy.gov.my/aeimages//File/MNMP_DUNAS.pdf. Accessed 24 April 2014
Ministry of Health Malaysia (2008a) Malaysia’s health [Online]. http://www.moh.gov.my/images/gallery/publications/mh/Malaysia%20Health%202008-2.pdf. Accessed 20 July 2014
Ministry of Health Malaysia (2008b) Malaysia’s health 2008. http://www.moh.gov.my/images/gallery/publications/mh/Malaysia%20Health%202008-2.pdf. Accessed 6 Nov 2012
Ministry of Health Malaysia (2012a) Malaysian National Medicines Policy. http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/buku-dunas.pdf. Accessed 12 Sept 2014
Ministry of Health Malaysia (2012a) Malaysian National Medicines Policy. http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/buku-dunas.pdf. Accessed 24 April 2014
Ministry of Health Malaysia (2012b) Pharmacoeconomic guideline for Malaysia [Online]. http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/pharmacoeconomic-guideline-malaysia.pdf. Accessed 28 Nov 2013
Ministry of Health Malaysia (2013) Health facts 2013. http://www.moh.gov.my/images/gallery/publications/HEALTH%20FACTS%202013.pdf. Accessed 18 Aug 2013
Ministry of Health Malaysia (2014) Outpatient charges [Online]. http://www.moh.gov.my/english.php/pages/view/151. Accessed 14 Jan 2014
National Pharmaceutical Control Bureau (2012a) About the Drug Control Authority [Online]. http://portal.bpfk.gov.my/index.cfm?&menuid=148&parentid=9. Accessed 13 Dec 2012
National Pharmaceutical Control Bureau (2012b) Drug registration guidance document. http://portal.bpfk.gov.my/aeimages//File/RGDOC_updated_Oct_2012_edited_121112.pdf. Accessed 13 Dec 2012
Ngadiman SA (2013) Financing ARV experience from Malaysia [Online]. https://www.google.com/webhp?source=search_app#q=malaysia+FLOW+OF+MOH+DRUG+FORMULARY+REVIEW+PANEL. Accessed 26 Nov 2013
Oorjitham S (2011) Competition countdown: level playing field [Online]. New Straits Times. http://www.nst.com.my/opinion/columnist/competition-countdown-level-playing-field-1.4678. Accessed 15 Dec 2012
Performance Management Delivery Unit (2012) Healthcare [Online]. http://etp.pemandu.gov.my/upload/Inside%20Investor%20-%20Healthcare.pdf. Accessed 5 March 2014
Performance Management Delivery Unit (2013a) About economic transformation program (ETP) [Online]. http://etp.pemandu.gov.my/About_ETP-@-Overview_of_ETP.aspx. Accessed 21 Nov 2013
Performance Management Delivery Unit (2013b) Healthcare NKEA fact sheet. http://etp.pemandu.gov.my/upload/NKEA_Factsheet_Healthcare.pdf. Accessed 23 Nov 2013
Performance Management Delivery Unit (2013c) National Key Economic Area (NKEA): health care [Online]. http://etp.pemandu.gov.my/upload/LINK_Healthcare_Event.pdf. Accessed 23 Nov 2013
Pharmaceutical Services Division Ministry of Health Malaysia (2012a) Malaysian National Medicines Policy [Online]. http://www.pharmacy.gov.my/v2/en/documents/malaysian-national-medicines-policy-dunas.html. Accessed 21 July 2014
Pharmaceutical Services Division Ministry of Health Malaysia (2012b) Pharmacoeconomic guideline for Malaysia, p 33. http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/pharmacoeconomic-guideline-malaysia.pdf
Shafie AA, Hassali MA (2008) Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia. J Generic Med 6:35–42
Sivalal S (2009) Health technology assessment in Malaysia. Int J Technol Assess Health Care 25:224–230
Social Security Association. Medical benefit [Online]. http://www.perkeso.gov.my/en/medical-benefit.html. Accessed 27 Jan 2014
Tandon A, Murray CJ, Lauer JA, Evans DB (2000) Measuring overall health system performance for 191 countries [Online]. http://www.who.int/healthinfo/paper30.pdf. Accessed 11 June 2013
Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AH, Aljadhey H (2014) Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders. J Pharm Health Serv Res. doi:10.1111/jphs.12072
World Health Organization (2011) System of Health Accounts (SHA 2011) [Online]. http://www.who.int/nha/sha_revision/en/. Accessed 20 Nov 2013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hassali, M.A., Tan, C.S., Wong, Z.Y., Saleem, F., Alrasheedy, A.A. (2015). Pharmaceutical Pricing in Malaysia. In: Babar, ZUD. (eds) Pharmaceutical Prices in the 21st Century. Adis, Cham. https://doi.org/10.1007/978-3-319-12169-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-12169-7_10
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-12168-0
Online ISBN: 978-3-319-12169-7
eBook Packages: Business and EconomicsEconomics and Finance (R0)